- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Valcyte is an antiviral drug mainly used to treat cytomegalovirus infection and related diseases, with the effects of inhibiting virus replicat...
Valcyte is an antiviral drug primarily used for the treatment and prevention of cytomegalovirus infection, particularly suitable for immunocomp...
Ruxolitinib is a JAK1/JAK2 kinase inhibitor mainly used to treat myeloproliferative tumors such as myelofibrosis and polycythemia vera, as well...
Mobocetinib is an oral EGFR tyrosine kinase inhibitor specifically targeting EGFR exon 20 insertion mutations, used to treat non-small cell lun...
Valcyte is an antiviral drug primarily used for the treatment and prevention of cytomegalovirus (CMV) infection, suitable for specific high-ris...
The correct use of Valcyte requires strict adherence to medical advice, and its dosage should be adjusted according to indications, patient wei...
The dosage of Ruxolitinib should be adjusted according to the indications, patient platelet count, and treatment response. The whole tablet sho...
Ruxolitinib has been launched in China and is suitable for the treatment of hematological diseases such as myelofibrosis and polycythemia vera....
Mobocertinib has not yet been officially listed in Chinese Mainland. When patients need to obtain it through overseas channels, they should pay...
Ruxolitinib, as a JAK1/2 inhibitor, has shown significant efficacy in hematological diseases such as myelofibrosis and polycythemia vera. Its ...
